These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14703959)

  • 21. 2-Acylamino-5-chlorobenzophenones with enhanced selectivity towards malaria parasites.
    Heinrich S; Altenkämper M; Bechem B; Perruchon J; Ortmann R; Dahse HM; Wang Y; Lanzer M; Schlitzer M
    Eur J Med Chem; 2011 Apr; 46(4):1331-42. PubMed ID: 21345543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability.
    Bulbule VJ; Rivas K; Verlinde CL; Van Voorhis WC; Gelb MH
    J Med Chem; 2008 Feb; 51(3):384-7. PubMed ID: 18198825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo.
    Wiesner J; Kettler K; Sakowski J; Ortmann R; Katzin AM; Kimura EA; Silber K; Klebe G; Jomaa H; Schlitzer M
    Angew Chem Int Ed Engl; 2004 Jan; 43(2):251-4. PubMed ID: 14695623
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-thiol farnesyltransferase inhibitors: N-(4-Acylamino-3-benzoylphenyl)-4-nitrocinnamic acid amides.
    Sakowski J; Sattler I; Schlitzer M
    Bioorg Med Chem; 2002 Feb; 10(2):233-9. PubMed ID: 11741771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimalarial activity of N(6)-substituted adenosine derivatives. Part 3.
    Herforth C; Wiesner J; Heidler P; Sanderbrand S; Van Calenbergh S; Jomaa H; Link A
    Bioorg Med Chem; 2004 Feb; 12(4):755-62. PubMed ID: 14759735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors.
    Lombardo LJ; Camuso A; Clark J; Fager K; Gullo-Brown J; Hunt JT; Inigo I; Kan D; Koplowitz B; Lee F; McGlinchey K; Qian L; Ricca C; Rovnyak G; Traeger S; Tokarski J; Williams DK; Wu LI; Zhao Y; Manne V; Bhide RS
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1895-9. PubMed ID: 15780629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts.
    Musonda CC; Taylor D; Lehman J; Gut J; Rosenthal PJ; Chibale K
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3901-5. PubMed ID: 15225694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides.
    Mitsch A; Wissner P; Silber K; Haebel P; Sattler I; Klebe G; Schlitzer M
    Bioorg Med Chem; 2004 Sep; 12(17):4585-600. PubMed ID: 15358286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Benzo[c][2,7]naphthyridine-2-yl-, 5-yl- and 2,5-diyl novaldiamines--synthesis and investigation of anti-malarial activity].
    Görlitzer K; Enge CH; Jones PG; Jomaa H; Wiesner J
    Pharmazie; 2006 Dec; 61(12):975-80. PubMed ID: 17283651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent and selective farnesyl transferase inhibitors.
    Millet R; Domarkas J; Houssin R; Gilleron P; Goossens JF; Chavatte P; Logé C; Pommery N; Pommery J; Hénichart JP
    J Med Chem; 2004 Dec; 47(27):6812-20. PubMed ID: 15615530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-thiol farnesyltransferase inhibitors: structure-activity relationships of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Schlitzer M; Böhm M; Sattler I
    Bioorg Med Chem; 2002 Mar; 10(3):615-20. PubMed ID: 11814849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antimalarial activity of substituted pyrazole derivatives.
    Domínguez JN; Charris JE; Caparelli M; Riggione F
    Arzneimittelforschung; 2002; 52(6):482-8. PubMed ID: 12109050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships of novel anti-malarial agents. Part 6: N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides.
    Wiesner J; Fucik K; Kettler K; Sakowski J; Ortmann R; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2003 May; 13(9):1539-41. PubMed ID: 12699750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by arylthienylacryloylaminobenzophenones.
    Mitsch A; Altenkämper M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2005 Jan; 338(1):9-17. PubMed ID: 15674808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
    Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
    Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitors.
    Li Q; Woods KW; Wang W; Lin NH; Claiborne A; Gu WZ; Cohen J; Stoll VS; Hutchins C; Frost D; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2033-9. PubMed ID: 15808463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D-QSAR analysis of antimalarial farnesyltransferase inhibitors based on a 2,5-diaminobenzophenone scaffold.
    Xie A; Sivaprakasam P; Doerksen RJ
    Bioorg Med Chem; 2006 Nov; 14(21):7311-23. PubMed ID: 16837204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformationally restrained aromatic analogues of fosmidomycin and FR900098.
    Kurz T; Schlüter K; Pein M; Behrendt C; Bergmann B; Walter RD
    Arch Pharm (Weinheim); 2007 Jul; 340(7):339-44. PubMed ID: 17611943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and evaluation of potent and selective benzoyleneurea-based inhibitors of protein geranylgeranyltransferase-I.
    Carrico D; Blaskovich MA; Bucher CJ; Sebti SM; Hamilton AD
    Bioorg Med Chem; 2005 Feb; 13(3):677-88. PubMed ID: 15653335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.